Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 91, Issue 3, Pages 550-554Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/clpt.2011.340
Keywords
-
Categories
Ask authors/readers for more resources
At the request of the Food and Drug Administration (FDA) and with its funding, the Panel on the Handling of Missing Data in Clinical Trials was created by the National Research Council's Committee on National Statistics. This panel recently published a report(1) with recommendations that will be of use not only to the FDA but also to the entire clinical trial community so that the latter can take measures to improve the conduct and analysis of clinical trials.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available